Profiel
Hilary Webber is currently the Chairman at Eqalis Pharmaceuticals Ltd.
Previously, Ms. Webber worked as an Independent Non-Executive Director at Cannasouth Ltd.
Actieve functies van Hilary Webber
Bedrijven | Functie | Begin |
---|---|---|
Eqalis Pharmaceuticals Ltd
Eqalis Pharmaceuticals Ltd Pharmaceuticals: MajorHealth Technology Part of Cannasouth Ltd., Eqalis Pharmaceuticals Ltd is a New Zealander company that manufactures cannabis-based pharmaceuticals. The company is based in Katikati, New Zealand. The CEO of the company is Greg Misson. Eqalis Pharmaceuticals was acquired by Cannasouth Ltd. on May 24, 2023 for $27.30 million. | Voorzitter | - |
Eerdere bekende functies van Hilary Webber
Bedrijven | Functie | Einde |
---|---|---|
CANNASOUTH LIMITED | Directeur/Bestuurslid | 01-01-2024 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
CANNASOUTH LIMITED | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Eqalis Pharmaceuticals Ltd
Eqalis Pharmaceuticals Ltd Pharmaceuticals: MajorHealth Technology Part of Cannasouth Ltd., Eqalis Pharmaceuticals Ltd is a New Zealander company that manufactures cannabis-based pharmaceuticals. The company is based in Katikati, New Zealand. The CEO of the company is Greg Misson. Eqalis Pharmaceuticals was acquired by Cannasouth Ltd. on May 24, 2023 for $27.30 million. | Health Technology |